Neuropathic pain: Evidence matters

European Journal of Pain

Volumn 6, Issue SUPPL. 1, 2002, Pages 11-18

  McQuay, Henry J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; IMIPRAMINE; MAPROTILINE; NORTRIPTYLINE; OPIATE DERIVATIVE; PAROXETINE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; NARCOTIC AGENT;

ANALGESIA; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; GAIT DISORDER; HUMAN; INCIDENCE; META ANALYSIS; MOLECULAR MECHANICS; NEUROPATHIC PAIN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TRIGEMINUS NEURALGIA; VISUAL IMPAIRMENT; XEROSTOMIA; ANIMAL; CHRONIC DISEASE; INTRACTABLE PAIN; NEURALGIA; PATHOPHYSIOLOGY; TREATMENT FAILURE;

ANALGESICS; ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; HUMANS; NARCOTICS; NEURALGIA; PAIN, INTRACTABLE; TREATMENT FAILURE;

EID: 0036372441     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.2001.0316     Document Type: Article

References (30)

1. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33: 11-23.
2. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E, for the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998; 280: 1831-1836.
3. Chadda V, Mathur M. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978; 26: 403-406.
4. Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Sympt Mgmt 2000; 20: 449-458.
5. Gomez-Perez FJ, Rull JA, Dies H, Rodriquez-Rivera JG, Gonzalez-Barranco J, Lozano-Castañeda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double blind cross over study. Pain 1985; 23: 395-400.
6. Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smoller B, Gracely RH, Dubner R. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47: 305-312.
7. Kvinesdal B, Molin D, Froland A, Gram LA. Imipramine therapy of painful diabetic neuropathy. JAMA 1984; 251: 1727-1730.
8. Matthews WB, Miller H. Diseases of the Nervous System. Oxford: Blackwell, 1972: 80.
9. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-1432.
10. Max MB, Kishore-Kumar R, Schafer SC, Meister B, Gracely RH, Smoller B, Dubner R. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991; 45: 3-9.
11. Max MB, Lynch SA, Muir J, Shoaf SF, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. NEJM 1992; 326: 1250-1256.
12. Mazars GJ, Choppy JM. Reevaluation of the deafferentation pain syndrome. In: Bonica JJ, Lindblom U, Iggo A, eds. Advances in Pain Research and Therapy, Vol 5. New York: Raven Press, 1983: 769-773.
13. McQuay HJ, Moore RA. An Evidence-based Resource for Pain Relief. Oxford: Oxford University Press, 1998.
14. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anti-convulsant drugs for management of pain: a systematic review. BMJ 1995; 311: 1047-1052.
15. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-227.
16. Mendel CM, Klein RF, Chappell DA, Dere WH, Gertz BJ, Karam JH, Lavin TM, Grunfeld C. A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy. JAMA 1986; 255: 637-639.
17. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998; 78: 209-216.
18. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L, for the Gabapentin Postherpetic Neuralgia Study Group. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998; 280: 1837-1842.
19. Rull J, Quibrera R, Gonzalz-Millan H, Lozano CO. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study. Diabetologia 1969; 5: 215-220.
20. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977; 22: 196-199.
21. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
22. Sindrup SH, Ejlertsen B, Frøland A, Sindrup EH, Brøsen K, Gram LF. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 1989; 37: 151-153.
23. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990a; 42: 135-144.
24. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H. Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990b; 30: 683-691.
25. Sindrup SH, Tuxen C, Gram LF, Grodum E, Skjold T, Brosen K, Beck-Nielsen H. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol 1992a; 43: 251-255.
26. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992b; 52: 547-552.
27. Tasker RR, Tsuda T, Hawrylyshyn P. Clinical neurophysiological investigation of deafferentation pain. In: Bonica JJ, Lindblom U, Iggo A, eds. Advances in Pain Research and Therapy. Vol. 5. New York: Raven Press, 1983: 713-738.
28. Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindström T, Thorell H. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and non-diabetics. Clin J Pain 1997; 13: 1-31.
29. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-673.
30. Young RJ, Clarke BF. Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs. Diabetic Med 1985; 2: 363-366.